MACOMBER LORI (EVP, CFO & Treasurer) sold 1.9% of their position (1.63K shares) of KARYOPHARM THERAPEUTICS INC. on the open market
Open‑market sale worth $10.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/4/2026ACC: 0001193125-26-037584
Officer· EVP, CFO & Treasurer
Since Feb 2026
-1.63K
Net shares
Net seller
$10.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.63K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.63K
Price / share
$6.30
Trade value
$10.24K
% of position
1.9%
2/3/2026
86.73K→85.11K
Total
Net shares
−1.63K
Net value
-$10.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2026 | S · Sale | −1.63K | $6.30 | $10.24K | 1.9% | 86.73K | 85.11K |
| Total | −1.63K | -$10.24K | ||||||
Derivative Transactions0
No derivative transactions reported